RJA
TBI

Raymond James & Associates’s Trueblue TBI Stock Holding History

Raymond James & Associates’s Portfolio TBI Stock Details TBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$423K Buy
53,620
+20,360
+61% +$183K ﹤0.01% 3202
2024
Q2 		$343K Buy
+33,260
New +$360K ﹤0.01% 3293

Other funds holding TBI

Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACM
Azarias Capital Management Berwyn, Pennsylvania $230M AUM 39.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Raymond James & Associates's TBI Position: Q3 2024 in Review

Raymond James & Associates increased its Trueblue (TBI) stake by 61% in Q3 2024, buying an estimated $183K and bringing the position to 53,620 shares worth $423K. The position accounts for ﹤0.01% of the portfolio, ranked #3202.

Raymond James & Associates first reported a position in TBI in Q2 2024 and has held it in 2 quarters since. 112 funds tracked by Wall St. Rank hold TBI as of Q3 2024.

  • Raymond James & Associates held 53,620 shares of Trueblue worth $423K as of Q3 2024.
  • Raymond James & Associates bought 20,360 Trueblue shares in Q3 2024, an estimated $183K.
  • Trueblue made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3202 holding.
  • Raymond James & Associates first reported a position in Trueblue in Q2 2024 and has held it in 2 quarters since.
  • 112 funds tracked by Wall St. Rank held Trueblue as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.